In This Issue:
- Can Experts Testify as to the Ethics or State of Mind of Corporate Defendants?
- Patent Reform for Biotech Companies
- United States v. Caronia and its Implications for Off-Label...more
5/22/2013
/ America Invents Act ,
Biotechnology ,
Daubert Standards ,
Ethics ,
Expert Testimony ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
First-to-File ,
Food and Drug Administration (FDA) ,
Free Speech ,
Off-Label Use ,
Patent Reform ,
Patents ,
Pharmaceutical Industry ,
Prior Use ,
Testimony